Kymera Therapeutics Market Cap

Kymera Therapeutics has a market cap or net worth of $2.16 billion as of May 17, 2024. Its market cap has increased by 38.38% in one year.

Market Cap

2.16B

Enterprise Value

1.72B

1-Year Change

38.38%

Ranking

#1889

Market Cap Chart

Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $2.16B, an increase of 158.45%. That is a compound annual growth rate of 28.91%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	2.14B	-1.83%
May 16, 2024	2.18B	-0.94%
May 15, 2024	2.21B	2.42%
May 14, 2024	2.15B	-8.52%
May 13, 2024	2.35B	1.21%
May 10, 2024	2.33B	-1.84%
May 9, 2024	2.37B	0.28%
May 8, 2024	2.36B	0.16%
May 7, 2024	2.36B	0.37%
May 6, 2024	2.35B	2.41%
May 3, 2024	2.29B	3.03%
May 2, 2024	2.23B	0.57%
May 1, 2024	2.21B	7.79%
Apr 30, 2024	2.05B	-3.00%
Apr 29, 2024	2.12B	3.86%
Apr 26, 2024	2.04B	0.06%
Apr 25, 2024	2.04B	-5.28%
Apr 24, 2024	2.15B	-1.40%
Apr 23, 2024	2.18B	3.96%
Apr 22, 2024	2.10B	1.12%
Apr 19, 2024	2.08B	-3.27%
Apr 18, 2024	2.15B	4.03%
Apr 17, 2024	2.06B	-0.50%
Apr 16, 2024	2.07B	-1.34%
Apr 15, 2024	2.10B	-3.35%

View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Dyne Therapeutics	2.24B
AMN Healthcare Services	2.23B
agilon health	2.23B
Deciphera Pharmaceuticals	2.20B
Integra LifeSciences Holdings	2.17B
Teladoc Health	2.15B
ADMA Biologics	2.13B
Amphastar Pharmaceuticals	2.13B

Market Cap Rankings